We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · January 06, 2020

Efficacy of Empagliflozin on Heart Failure and Renal Outcomes in Patients With Atrial Fibrillation

European Journal of Heart Failure

 

Additional Info

European Journal of Heart Failure
Efficacy of Empagliflozin on Heart Failure and Renal Outcomes in Patients With Atrial Fibrillation: Data From the EMPA-REG OUTCOME Trial
Eur. J. Heart Fail 2019 Dec 09;[EPub Ahead of Print], M Böhm, J Slawik, M Brueckmann, M Mattheus, JT George, AP Ofstad, SE Inzucchi, D Fitchett, SD Anker, N Marx, C Wanner, B Zinman, S Verma

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading